Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis

  • STATUS
    Recruiting
  • End date
    Jul 1, 2023
  • participants needed
    104
  • sponsor
    University of Liege
Updated on 8 August 2021

Summary

To find superiority relationship between oral and intravenous administration of tranexamic acid on peroperative and postoperative blood loss, haemarthrosis prevalence and improvement functional prognosis in anterior cruciate ligament arthroscopy.

Description

Tranexamic acid is an anti-fibrinolytic drug, recommended in total hip arthroplasty to reduce peroperative and postoperative hemorrhagic complications. The original character of our study lies in the serum dosage of tranexamic acid, allowing to correlate the primary objective (blood loss) with this one. The investigators will focus on the reduction of the risks associated with the administration of intravenous medicines, the economic aspect and the ease of use.

Details
Condition Exsanguination, Arthroscopy, Postoperative Hemorrhage, Anterior Cruciate Ligament Tear, Rupture of Anterior Cruciate Ligament, Anterior Cruciate Ligament Rupture, postoperative bleeding, postoperative blood loss
Treatment Placebo, Oral Tablet
Clinical Study IdentifierNCT04855877
SponsorUniversity of Liege
Last Modified on8 August 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Primary arthroscopic surgery for anterior cruciate ligament reconstruction

Exclusion Criteria

Renal failure with serum creatinine level higher than 1,40 mg/dL
Thromboembolic events in last 12 months before surgery
Pregnancy
Congenital or acquired coagulation diseases
History of gastric surgery that could lead to malabsorption
Diabetic gastro-paresis
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note